GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results